The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease

Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significanc...

Full description

Saved in:
Bibliographic Details
Published inLife sciences (1973) Vol. 207; pp. 145 - 151
Main Authors Fei, Yu, Hou, Jianhua, Xuan, Wei, Zhang, Chenghua, Meng, Xiuping
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 15.08.2018
Elsevier BV
Subjects
Online AccessGet full text
ISSN0024-3205
1879-0631
1879-0631
DOI10.1016/j.lfs.2018.06.001

Cover

Abstract Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease. Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis. Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively. Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC.
AbstractList Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease.Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis.Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively.Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC.
Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease.OBJECTIVEAlthough angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease.Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis.METHODSAmong patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis.Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively.RESULTSOur data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively.Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC.CONCLUSIONSLower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC.
Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease. Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis. Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively. Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC.
Objective Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they cannot fully explain the mechanism of CCC formation or as potent biomarker for CCC status. Therefore, there is of great clinical significance to identify the novel molecules associated with CCC. Previously, miR-503 exerts anti-angiogenesis effect via inhibition of VEGF-A and its expression is associated with many angiogenesis-related factors. Thus, we aimed to investigate the relationship of plasma miR-503 with CCC formation as well as its predictive power for CCC status in patients with coronary artery disease. Methods Among patients who underwent coronary angiography with coronary artery disease and a stenosis of ≥90% were included in our study. Collateral degree was graded according to Rentrop Cohen classification. The patients were divided to good CCC group (grade 2 or 3) and poor CCC group (grade 0 or 1) according to Rentrop grade. We investigated the plasma levels of miR-503 and VEGF-A by ELISA or q RT-PCR, respectively. In addition, we assayed the correlations of plasma miR-503 with VEGF-A or Rentrop grade using the spearman correlation test and its predictive power by receiver operating characteristic (ROC) and binary logistical regression analysis. Results Our data showed that plasma VEGF-A was significantly higher in good CCC group than that in poor group. Plasma miR-503 was lower in CAD patients with good CCC or poor CCC compared with control subjects and lowest in good CCC group. In addition, miR-503 negatively correlated with VEGF-A and Rentrop grade, respectively. Moreover, miR-503 displayed more potent predictive power for CCC status than VEGF-A, but its sensitivity and specificity for CCC status were only 72.4 or 60.9%, respectively. Conclusions Lower plasma miR-503 level was related to better CCC formation, accompanied by up-regulation of VEGF-A. In addition, miR-503 displayed potent predictive power for CCC status, but its sensitivity and specificity were not high enough, indicating that miR-503 might be as an additional prognosis biomarker for CCC.
Author Xuan, Wei
Fei, Yu
Hou, Jianhua
Zhang, Chenghua
Meng, Xiuping
Author_xml – sequence: 1
  givenname: Yu
  surname: Fei
  fullname: Fei, Yu
  organization: Department of Cardiology, The Second Hospital, Jilin University, No. 218 Ziqiang Street, Changchun 130041, China
– sequence: 2
  givenname: Jianhua
  surname: Hou
  fullname: Hou, Jianhua
  organization: Department of Orthodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China
– sequence: 3
  givenname: Wei
  surname: Xuan
  fullname: Xuan, Wei
  organization: Department of Hepatopancreaticobiliary Surgery, China-Japan Union Hospital, Jilin University, Changchun 130041, China
– sequence: 4
  givenname: Chenghua
  surname: Zhang
  fullname: Zhang, Chenghua
  organization: Department of Endoscopy, Jilin Cancer Hospital, Changchun 130021, China
– sequence: 5
  givenname: Xiuping
  surname: Meng
  fullname: Meng, Xiuping
  email: mxp208408@sina.com
  organization: Department of Endodontics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29870767$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1r3DAQhkVJaTZpf0AvRdBLL3ZHliXZ9FRCvyBQKOlZyPKI1WJLrmQ35N9X200o5JCeNIfnGTTve0HOQgxIyGsGNQMm3x_qyeW6AdbVIGsA9ozsWKf6CiRnZ2QH0LQVb0Cck4ucDwAghOIvyHnTdwqUVDsSb_ZIE05m9THkvV9odHSZTJ4Nnf2PSgCnJozUxhSDSXdlmAqMyUzU-mS3k0l9oEuZMKyZ3vp1_08wqdB3dPQZTcaX5LkzU8ZX9-8l-fn5083V1-r6-5dvVx-vK9uydq0k5-3QqkF0KARXorGc970dnGW944NwcmADdqI3rlwvOgaqG60cW-dG3nLHL8m7094lxV8b5lXPPlssfw8Yt6ybEiBnXPHm_ygIBrJnnBf07SP0ELcUyiHHhW0vmFBQqDf31DbMOOol-bkkoR9SL4A6ATbFnBM6bf36N8c1GT9pBvrYrz7o0q8-9qtB6tJvMdkj82H5U86Hk4Ml798ek862FGVx9Antqsfon7D_ANMCvH4
CitedBy_id crossref_primary_10_1007_s12975_020_00794_0
crossref_primary_10_1186_s12885_018_5017_y
crossref_primary_10_1360_SSV_2021_0252
crossref_primary_10_1097_HJH_0000000000002413
crossref_primary_10_2147_DMSO_S262888
crossref_primary_10_1007_s00018_018_2971_0
crossref_primary_10_2174_1568026623666221221124530
crossref_primary_10_3390_biomedicines11041037
crossref_primary_10_15829_1728_8800_2024_4086
crossref_primary_10_3390_jcm13061742
crossref_primary_10_15829_1728_8800_2024_4190
crossref_primary_10_20945_2359_3997000000218
crossref_primary_10_3389_fcvm_2021_770574
crossref_primary_10_1016_j_biocel_2022_106294
crossref_primary_10_3389_fphar_2021_629611
crossref_primary_10_2147_DDDT_S336826
crossref_primary_10_4239_wjd_v13_i11_926
crossref_primary_10_23736_S0026_4725_20_04995_6
Cites_doi 10.1016/S0165-6147(00)01676-X
10.2217/bmm-2016-0282
10.1016/j.vph.2011.06.006
10.1172/JCI42980
10.1016/j.ccep.2017.08.003
10.1161/CIRCULATIONAHA.110.952325
10.1093/cvr/cvn156
10.1155/2016/4285942
10.1371/journal.pone.0000116
10.2337/db15-1668
10.1093/cvr/cvt234
10.1038/nrcardio.2013.207
10.1016/j.jacl.2014.11.003
10.1016/S0002-9149(83)80105-2
10.1016/j.clinbiochem.2012.02.009
10.1093/eurheartj/eht195
10.1111/j.1440-1681.2008.05057.x
10.1161/CIRCRESAHA.108.191270
10.1161/ATVBAHA.112.300142
10.1097/MCA.0000000000000115
10.1016/j.phrs.2012.09.005
10.1016/j.yjmcc.2011.12.006
10.1096/fj.201700617R
10.1038/nm.3040
10.1093/cvr/cvv104
10.1016/j.canlet.2013.01.028
ContentType Journal Article
Copyright 2018
Copyright © 2018. Published by Elsevier Inc.
Copyright Elsevier BV Aug 15, 2018
Copyright_xml – notice: 2018
– notice: Copyright © 2018. Published by Elsevier Inc.
– notice: Copyright Elsevier BV Aug 15, 2018
DBID AAYXX
CITATION
NPM
7QP
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
RC3
7X8
7S9
L.6
DOI 10.1016/j.lfs.2018.06.001
DatabaseName CrossRef
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
PubMed
Genetics Abstracts
Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE - Academic
PubMed

Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Biology
EISSN 1879-0631
EndPage 151
ExternalDocumentID 29870767
10_1016_j_lfs_2018_06_001
S0024320518303424
Genre Journal Article
GroupedDBID ---
--K
--M
-~X
.~1
0R~
1B1
1RT
1~.
4.4
457
5GY
5RE
5VS
6TJ
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABLJU
ABLVK
ABMAC
ABMZM
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACIWK
ACPRK
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFRAH
AFTJW
AFXIZ
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
C45
CNWQP
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IH2
IHE
J1W
K-O
KOM
L7B
LCYCR
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SDF
SDG
SDP
SES
SPCBC
SSH
SSP
SSZ
T5K
TEORI
YZZ
~G-
.55
.GJ
29L
3O-
53G
AAHBH
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ABXDB
ACIEU
ACLOT
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEIPS
AEUPX
AFFNX
AFJKZ
AFPUW
AGHFR
AGQPQ
AHHHB
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
CITATION
EFKBS
FEDTE
FGOYB
G-2
HMG
HMT
HVGLF
HZ~
H~9
J5H
MVM
R2-
SEW
SIN
SPT
WUQ
X7M
Y6R
YYP
ZGI
ZKB
ZXP
ZY4
~HD
NPM
7QP
7QR
7TK
7U7
7U9
8FD
AGCQF
C1K
FR3
H94
P64
RC3
7X8
7S9
L.6
ID FETCH-LOGICAL-c414t-6334b47b58e553752c3399cbfc19f3b5f6b1be859af018581078dc6d4ffd343f3
IEDL.DBID .~1
ISSN 0024-3205
1879-0631
IngestDate Sun Sep 28 12:35:40 EDT 2025
Sat Sep 27 22:09:46 EDT 2025
Wed Aug 13 11:22:24 EDT 2025
Wed Feb 19 02:41:46 EST 2025
Wed Oct 01 05:07:44 EDT 2025
Thu Apr 24 23:01:42 EDT 2025
Fri Feb 23 02:25:40 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords VEGF-A
Gensini score
Coronary collateral circulation
miR-503
Rentrop grade
Language English
License Copyright © 2018. Published by Elsevier Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c414t-6334b47b58e553752c3399cbfc19f3b5f6b1be859af018581078dc6d4ffd343f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 29870767
PQID 2104951570
PQPubID 2045439
PageCount 7
ParticipantIDs proquest_miscellaneous_2101313732
proquest_miscellaneous_2051069133
proquest_journals_2104951570
pubmed_primary_29870767
crossref_citationtrail_10_1016_j_lfs_2018_06_001
crossref_primary_10_1016_j_lfs_2018_06_001
elsevier_sciencedirect_doi_10_1016_j_lfs_2018_06_001
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-08-15
PublicationDateYYYYMMDD 2018-08-15
PublicationDate_xml – month: 08
  year: 2018
  text: 2018-08-15
  day: 15
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: New York
PublicationTitle Life sciences (1973)
PublicationTitleAlternate Life Sci
PublicationYear 2018
Publisher Elsevier Inc
Elsevier BV
Publisher_xml – name: Elsevier Inc
– name: Elsevier BV
References Wang, Yan, Song (bb0045) 2017; 11
Wang, Qian, Zhang (bb0070) 2009; 36
Prosser, Tan, Dunn (bb0125) 2013; 101
Dang, Lawson, Fish (bb0035) 2013; 33
Hua, Lv, Ye (bb0110) 2006; 1
Khoo, Shen, Zhao (bb0075) 2014; 25
Zimarino, D'andreamatteo, Waksman (bb0015) 2014; 11
Tan, Ng, Bursill (bb0120) 2015; 106
Zhou, Ma, Si (bb0050) 2013; 333
Foussas, Tsiaousis (bb0010) 2008; 12
Gensini (bb0085) 1983; 51
Jin, Hagemann, Sun (bb0140) 2018
Caporali, Emanueli (bb0025) 2011; 55
Cannizzo, Adonopulos, Solly (bb0145) 2018; 32
Caporali, Meloni, Völlenkle (bb0055) 2011; 123
Kim, Kang, Kojima (bb0060) 2013; 19
Tan, Prosser, Dunn (bb0135) 2016; 65
Tomasetti, Staffolani, Nocchi (bb0080) 2012; 45
Cross, Claesson-Welsh (bb0105) 2001; 22
Muñoz-Pacheco, Ortega-Hernández, Miana (bb0065) 2012; 66
Suarez, Sessa (bb0030) 2009; 104
Ghosh, Subramanian, Adhikari (bb0100) 2010; 120
Wang, Yan, Song (bb0115) 2016; 2016
Sayın, Çetiner, Karabağ (bb0090) 2012
Xu, Li, Li (bb0150) 2015; 9
Chilian, Penn, Pung (bb0095) 2012; 52
Urbich, Kuehbacher, Dimmeler (bb0040) 2008; 79
El-Sherif, Boutjdir, Turitto (bb0005) 2017; 9
Seiler, Stoller, Pitt (bb0020) 2013; 34
Zimarino (10.1016/j.lfs.2018.06.001_bb0015) 2014; 11
Muñoz-Pacheco (10.1016/j.lfs.2018.06.001_bb0065) 2012; 66
Kim (10.1016/j.lfs.2018.06.001_bb0060) 2013; 19
Caporali (10.1016/j.lfs.2018.06.001_bb0025) 2011; 55
El-Sherif (10.1016/j.lfs.2018.06.001_bb0005) 2017; 9
Wang (10.1016/j.lfs.2018.06.001_bb0070) 2009; 36
Tomasetti (10.1016/j.lfs.2018.06.001_bb0080) 2012; 45
Gensini (10.1016/j.lfs.2018.06.001_bb0085) 1983; 51
Jin (10.1016/j.lfs.2018.06.001_bb0140) 2018
Wang (10.1016/j.lfs.2018.06.001_bb0045) 2017; 11
Xu (10.1016/j.lfs.2018.06.001_bb0150) 2015; 9
Suarez (10.1016/j.lfs.2018.06.001_bb0030) 2009; 104
Khoo (10.1016/j.lfs.2018.06.001_bb0075) 2014; 25
Hua (10.1016/j.lfs.2018.06.001_bb0110) 2006; 1
Seiler (10.1016/j.lfs.2018.06.001_bb0020) 2013; 34
Urbich (10.1016/j.lfs.2018.06.001_bb0040) 2008; 79
Prosser (10.1016/j.lfs.2018.06.001_bb0125) 2013; 101
Caporali (10.1016/j.lfs.2018.06.001_bb0055) 2011; 123
Tan (10.1016/j.lfs.2018.06.001_bb0120) 2015; 106
Cross (10.1016/j.lfs.2018.06.001_bb0105) 2001; 22
Zhou (10.1016/j.lfs.2018.06.001_bb0050) 2013; 333
Sayın (10.1016/j.lfs.2018.06.001_bb0090) 2012
Tan (10.1016/j.lfs.2018.06.001_bb0135) 2016; 65
Foussas (10.1016/j.lfs.2018.06.001_bb0010) 2008; 12
Cannizzo (10.1016/j.lfs.2018.06.001_bb0145) 2018; 32
Ghosh (10.1016/j.lfs.2018.06.001_bb0100) 2010; 120
Dang (10.1016/j.lfs.2018.06.001_bb0035) 2013; 33
Chilian (10.1016/j.lfs.2018.06.001_bb0095) 2012; 52
Wang (10.1016/j.lfs.2018.06.001_bb0115) 2016; 2016
References_xml – volume: 123
  start-page: 282
  year: 2011
  end-page: 291
  ident: bb0055
  article-title: Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia
  publication-title: Circulation
– volume: 19
  start-page: 74
  year: 2013
  end-page: 82
  ident: bb0060
  article-title: An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension[J]
  publication-title: Nat. Med.
– volume: 79
  start-page: 581
  year: 2008
  end-page: 588
  ident: bb0040
  article-title: Role of microRNAs in vascular diseases, inflammation, and angiogenesis[J]
  publication-title: Cardiovasc. Res.
– volume: 32
  start-page: 2911
  year: 2018
  end-page: 2922
  ident: bb0145
  article-title: VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia[J]
  publication-title: FASEB J.
– volume: 34
  start-page: 2674
  year: 2013
  end-page: 2682
  ident: bb0020
  article-title: The human coronary collateral circulation: development and clinical importance[J]
  publication-title: Eur. Heart J.
– volume: 25
  start-page: 493
  year: 2014
  end-page: 497
  ident: bb0075
  article-title: Determination of the severity of underlying lesions in acute myocardial infarction on the basis of collateral vessel development[J]
  publication-title: Coron. Artery Dis.
– volume: 2016
  year: 2016
  ident: bb0115
  article-title: Reduced plasma miR-146a is a predictor of poor coronary collateral circulation in patients with coronary artery disease[J]
  publication-title: Biomed. Res. Int.
– volume: 45
  start-page: 575
  year: 2012
  end-page: 581
  ident: bb0080
  article-title: Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients[J]
  publication-title: Clin. Biochem.
– volume: 55
  start-page: 79
  year: 2011
  end-page: 86
  ident: bb0025
  article-title: MicroRNA regulation in angiogenesis[J]
  publication-title: Vasc. Pharmacol.
– volume: 104
  start-page: 442
  year: 2009
  end-page: 454
  ident: bb0030
  article-title: MicroRNAs as novel regulators of angiogenesis[J]
  publication-title: Circ. Res.
– volume: 11
  start-page: 191
  year: 2014
  end-page: 197
  ident: bb0015
  article-title: The dynamics of the coronary collateral circulation[J]
  publication-title: Nat. Rev. Cardiol.
– volume: 120
  start-page: 4141
  year: 2010
  end-page: 4154
  ident: bb0100
  article-title: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis[J]
  publication-title: J. Clin. Invest.
– volume: 1
  year: 2006
  ident: bb0110
  article-title: MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia[J]
  publication-title: PLoS One
– volume: 11
  start-page: 125
  year: 2017
  end-page: 131
  ident: bb0045
  article-title: The association of plasma miR-155 and VCAM-1 levels with coronary collateral circulation[J]
  publication-title: Biomark. Med
– volume: 33
  start-page: 193
  year: 2013
  end-page: 200
  ident: bb0035
  article-title: MicroRNA control of vascular endothelial growth factor signaling output during vascular development[J]
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– start-page: 1
  year: 2018
  end-page: 14
  ident: bb0140
  article-title: High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation[J]
  publication-title: Angiogenesis
– volume: 101
  start-page: 145
  year: 2013
  end-page: 154
  ident: bb0125
  article-title: Multifunctional regulation of angiogenesis by high-density lipoproteins[J]
  publication-title: Cardiovasc. Res.
– volume: 9
  start-page: 681
  year: 2017
  end-page: 691
  ident: bb0005
  article-title: Sudden cardiac death in ischemic heart disease: pathophysiology and risk stratification[J]
  publication-title: Card. Electrophysiol. Clin.
– volume: 12
  start-page: 3
  year: 2008
  end-page: 10
  ident: bb0010
  article-title: Revascularization treatment in patients with coronary artery disease[J]
  publication-title: Hippokratia
– volume: 36
  start-page: 181
  year: 2009
  end-page: 188
  ident: bb0070
  article-title: MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats[J]
  publication-title: Clin. Exp. Pharmacol. Physiol.
– volume: 22
  start-page: 201
  year: 2001
  end-page: 207
  ident: bb0105
  article-title: FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition[J]
  publication-title: Trends Pharmacol. Sci.
– volume: 66
  start-page: 536
  year: 2012
  end-page: 543
  ident: bb0065
  article-title: Ezetimibe inhibits PMA-induced monocyte/macrophage differentiation by altering microRNA expression: a novel anti-atherosclerotic mechanism[J]
  publication-title: Pharmacol. Res.
– volume: 52
  start-page: 905
  year: 2012
  end-page: 911
  ident: bb0095
  article-title: Coronary collateral growth—back to the future[J]
  publication-title: J. Mol. Cell. Cardiol.
– start-page: 51
  year: 2012
  end-page: 54
  ident: bb0090
  article-title: The Relationship Between the Gensini Score and Complete Blood Count Parameters in Coronary Artery Disease[J]
– volume: 9
  start-page: 26
  year: 2015
  end-page: 34
  ident: bb0150
  article-title: High-density lipoprotein subfractions in relation with the severity of coronary artery disease: a Gensini score assessment[J]
  publication-title: J. Clin. Lipidol.
– volume: 65
  start-page: 3091
  year: 2016
  end-page: 3103
  ident: bb0135
  article-title: High-density lipoproteins rescue diabetes-impaired angiogenesis via scavenger receptor class B type I[J]
  publication-title: Diabetes
– volume: 51
  start-page: 606
  year: 1983
  ident: bb0085
  article-title: A more meaningful scoring system for determining the severity of coronary heart disease[J]
  publication-title: Am. J. Cardiol.
– volume: 106
  start-page: 184
  year: 2015
  end-page: 193
  ident: bb0120
  article-title: The role of high-density lipoproteins in the regulation of angiogenesis[J]
  publication-title: Cardiovasc. Res.
– volume: 333
  start-page: 159
  year: 2013
  end-page: 169
  ident: bb0050
  article-title: MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth[J]
  publication-title: Cancer Lett.
– volume: 22
  start-page: 201
  issue: 4
  year: 2001
  ident: 10.1016/j.lfs.2018.06.001_bb0105
  article-title: FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition[J]
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/S0165-6147(00)01676-X
– volume: 12
  start-page: 3
  issue: 1
  year: 2008
  ident: 10.1016/j.lfs.2018.06.001_bb0010
  article-title: Revascularization treatment in patients with coronary artery disease[J]
  publication-title: Hippokratia
– volume: 11
  start-page: 125
  issue: 2
  year: 2017
  ident: 10.1016/j.lfs.2018.06.001_bb0045
  article-title: The association of plasma miR-155 and VCAM-1 levels with coronary collateral circulation[J]
  publication-title: Biomark. Med
  doi: 10.2217/bmm-2016-0282
– volume: 55
  start-page: 79
  issue: 4
  year: 2011
  ident: 10.1016/j.lfs.2018.06.001_bb0025
  article-title: MicroRNA regulation in angiogenesis[J]
  publication-title: Vasc. Pharmacol.
  doi: 10.1016/j.vph.2011.06.006
– volume: 120
  start-page: 4141
  issue: 11
  year: 2010
  ident: 10.1016/j.lfs.2018.06.001_bb0100
  article-title: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis[J]
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI42980
– volume: 9
  start-page: 681
  issue: 4
  year: 2017
  ident: 10.1016/j.lfs.2018.06.001_bb0005
  article-title: Sudden cardiac death in ischemic heart disease: pathophysiology and risk stratification[J]
  publication-title: Card. Electrophysiol. Clin.
  doi: 10.1016/j.ccep.2017.08.003
– volume: 123
  start-page: 282
  year: 2011
  ident: 10.1016/j.lfs.2018.06.001_bb0055
  article-title: Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.952325
– volume: 79
  start-page: 581
  issue: 4
  year: 2008
  ident: 10.1016/j.lfs.2018.06.001_bb0040
  article-title: Role of microRNAs in vascular diseases, inflammation, and angiogenesis[J]
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvn156
– start-page: 1
  year: 2018
  ident: 10.1016/j.lfs.2018.06.001_bb0140
  article-title: High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation[J]
  publication-title: Angiogenesis
– volume: 2016
  year: 2016
  ident: 10.1016/j.lfs.2018.06.001_bb0115
  article-title: Reduced plasma miR-146a is a predictor of poor coronary collateral circulation in patients with coronary artery disease[J]
  publication-title: Biomed. Res. Int.
  doi: 10.1155/2016/4285942
– volume: 1
  issue: 1
  year: 2006
  ident: 10.1016/j.lfs.2018.06.001_bb0110
  article-title: MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia[J]
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0000116
– volume: 65
  start-page: 3091
  issue: 10
  year: 2016
  ident: 10.1016/j.lfs.2018.06.001_bb0135
  article-title: High-density lipoproteins rescue diabetes-impaired angiogenesis via scavenger receptor class B type I[J]
  publication-title: Diabetes
  doi: 10.2337/db15-1668
– volume: 101
  start-page: 145
  issue: 1
  year: 2013
  ident: 10.1016/j.lfs.2018.06.001_bb0125
  article-title: Multifunctional regulation of angiogenesis by high-density lipoproteins[J]
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvt234
– volume: 11
  start-page: 191
  issue: 4
  year: 2014
  ident: 10.1016/j.lfs.2018.06.001_bb0015
  article-title: The dynamics of the coronary collateral circulation[J]
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/nrcardio.2013.207
– volume: 9
  start-page: 26
  issue: 1
  year: 2015
  ident: 10.1016/j.lfs.2018.06.001_bb0150
  article-title: High-density lipoprotein subfractions in relation with the severity of coronary artery disease: a Gensini score assessment[J]
  publication-title: J. Clin. Lipidol.
  doi: 10.1016/j.jacl.2014.11.003
– volume: 51
  start-page: 606
  issue: 3
  year: 1983
  ident: 10.1016/j.lfs.2018.06.001_bb0085
  article-title: A more meaningful scoring system for determining the severity of coronary heart disease[J]
  publication-title: Am. J. Cardiol.
  doi: 10.1016/S0002-9149(83)80105-2
– start-page: 51
  year: 2012
  ident: 10.1016/j.lfs.2018.06.001_bb0090
– volume: 45
  start-page: 575
  issue: 7–8
  year: 2012
  ident: 10.1016/j.lfs.2018.06.001_bb0080
  article-title: Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients[J]
  publication-title: Clin. Biochem.
  doi: 10.1016/j.clinbiochem.2012.02.009
– volume: 34
  start-page: 2674
  issue: 34
  year: 2013
  ident: 10.1016/j.lfs.2018.06.001_bb0020
  article-title: The human coronary collateral circulation: development and clinical importance[J]
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/eht195
– volume: 36
  start-page: 181
  issue: 2
  year: 2009
  ident: 10.1016/j.lfs.2018.06.001_bb0070
  article-title: MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats[J]
  publication-title: Clin. Exp. Pharmacol. Physiol.
  doi: 10.1111/j.1440-1681.2008.05057.x
– volume: 104
  start-page: 442
  issue: 4
  year: 2009
  ident: 10.1016/j.lfs.2018.06.001_bb0030
  article-title: MicroRNAs as novel regulators of angiogenesis[J]
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.108.191270
– volume: 33
  start-page: 193
  issue: 2
  year: 2013
  ident: 10.1016/j.lfs.2018.06.001_bb0035
  article-title: MicroRNA control of vascular endothelial growth factor signaling output during vascular development[J]
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.112.300142
– volume: 25
  start-page: 493
  issue: 6
  year: 2014
  ident: 10.1016/j.lfs.2018.06.001_bb0075
  article-title: Determination of the severity of underlying lesions in acute myocardial infarction on the basis of collateral vessel development[J]
  publication-title: Coron. Artery Dis.
  doi: 10.1097/MCA.0000000000000115
– volume: 66
  start-page: 536
  issue: 6
  year: 2012
  ident: 10.1016/j.lfs.2018.06.001_bb0065
  article-title: Ezetimibe inhibits PMA-induced monocyte/macrophage differentiation by altering microRNA expression: a novel anti-atherosclerotic mechanism[J]
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2012.09.005
– volume: 52
  start-page: 905
  issue: 4
  year: 2012
  ident: 10.1016/j.lfs.2018.06.001_bb0095
  article-title: Coronary collateral growth—back to the future[J]
  publication-title: J. Mol. Cell. Cardiol.
  doi: 10.1016/j.yjmcc.2011.12.006
– volume: 32
  start-page: 2911
  issue: 6
  year: 2018
  ident: 10.1016/j.lfs.2018.06.001_bb0145
  article-title: VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia[J]
  publication-title: FASEB J.
  doi: 10.1096/fj.201700617R
– volume: 19
  start-page: 74
  issue: 1
  year: 2013
  ident: 10.1016/j.lfs.2018.06.001_bb0060
  article-title: An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension[J]
  publication-title: Nat. Med.
  doi: 10.1038/nm.3040
– volume: 106
  start-page: 184
  issue: 2
  year: 2015
  ident: 10.1016/j.lfs.2018.06.001_bb0120
  article-title: The role of high-density lipoproteins in the regulation of angiogenesis[J]
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvv104
– volume: 333
  start-page: 159
  issue: 2
  year: 2013
  ident: 10.1016/j.lfs.2018.06.001_bb0050
  article-title: MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth[J]
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2013.01.028
SSID ssj0005573
Score 2.3684125
Snippet Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary angiogenesis, they...
Objective Although angiogenesis plays an important role in coronary collateral circulation (CCC) formation and there are many determinants of coronary...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 145
SubjectTerms angiogenesis
Angiography
Biomarkers
Cardiovascular disease
Coronary artery
Coronary artery disease
Coronary collateral circulation
coronary vessels
Correlation
enzyme-linked immunosorbent assay
Gensini score
miR-503
patients
Plasma
prognosis
Proteins
Regression analysis
Rentrop grade
reverse transcriptase polymerase chain reaction
Ribonucleic acid
RNA
Sensitivity
vascular endothelial growth factor A
VEGF-A
Title The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease
URI https://dx.doi.org/10.1016/j.lfs.2018.06.001
https://www.ncbi.nlm.nih.gov/pubmed/29870767
https://www.proquest.com/docview/2104951570
https://www.proquest.com/docview/2051069133
https://www.proquest.com/docview/2101313732
Volume 207
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1879-0631
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005573
  issn: 0024-3205
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1879-0631
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005573
  issn: 0024-3205
  databaseCode: ACRLP
  dateStart: 19950526
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1879-0631
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005573
  issn: 0024-3205
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1879-0631
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005573
  issn: 0024-3205
  databaseCode: AIKHN
  dateStart: 19950526
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1879-0631
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005573
  issn: 0024-3205
  databaseCode: AKRWK
  dateStart: 19930101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CSqGX0KRtsmkaVOghLThZeSTLPobQsG0hh5JAbsaSJeKw8S6bzWEv_e2dseVtC-0eerQsGVnzlGb0DcCHXJIXqqxKjDOYKIeeZI7kSmldB68sNXRon1fZ5EZ9vdW3W3Ax3IXhtMqo-3ud3mnr2HIWV_Ns3jR8xzdVmBJT5cg4dowJyuhfxNOnP35L89AxypyqhHsPkc0ux2saGLFb9hCesS7MX2zTv3zPzgZdvoSd6DyK835-u7Dl2z143peTXO3BbhTUR3ES0aQ_voIZMYJYDClvd81czIKYk8_8UImH5nuixyiqthaOoQyqxUp0nMH3kqfCNQsXy3uJphURg_VR8OHtrwFdVuhKxFDPa7i5_Hx9MUlilYXEKamWSYZItDJW515rNDp1SE6Ls8HJIqDVIbPS-lwXVaCV0jntF_PaZbUKoUaFAd_Adjtr_QEI6TTZO23Jq0GVV86idGmtCpN6HPtqPILxsL6lixDkXAljWg65ZvclkaRkkpR9vt0IPq2HzHv8jU2d1UC08g8mKsk-bBp2NBC4jBJM72mfSt6nNjTr9-vXJHscUKlaP3vib5BGywra5m_oIxnRCA2mI9jvmWf9I2lB2tJk5vD_5v0WXvATn3BLfQTby8WTf0cu0tIedzJwDM_Ov3ybXP0EI6wNzw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED-xomm8TIN9dbDNk_awTYqoc3acPCIEKoP1YQKJNyt2bC1TSatSHvrfc06cIqStD7zavsjxffjsO_8O4GvOyQsVRiTKKkyERUc6R3olpKy8E4YaWrTPSTa-Ej-v5fUWHPdvYUJaZbT9nU1vrXVsOYyreTiv6_DGNxWYklDlGHDsxDPYFpJs8gC2j87Ox5OHTA8ZA82pSAJBH9xs07ymPoB28w7FM5aG-cf29D_3s92GTl_By-g_sqNuiruw5Zo9eN5VlFztwW7U1Vv2LQJKf38NM5IFtuiz3v7UczbzbE5u803JburfiRwhK5uK2YBmUC5WrBWO8DR5ymy9sLHCF6sbFmFYb1m4v30gaBNDVyxGe97A1enJ5fE4iYUWEiu4WCYZIrFLGZk7KVHJ1CL5LdZ4ywuPRvrMcONyWZSeVkrmdGTMK5tVwvsKBXp8C4Nm1rj3wLiVtOVJQ44Niry0BrlNK1Go1OHIlaMhjPr11TaikIdiGFPdp5v91cQSHViiu5S7IfxYk8w7CI5Ng0XPNP1IjjRtEZvIDnoG66jE1E9HVXJApaJZf1l3k_qFmErZuNld-AYZtaygk_6GMTyAGqHCdAjvOuFZ_0hakMFUmfrwtHl_hhfjy18X-uJscr4PO6EnXHhzeQCD5eLOfSSPaWk-RY24B0igEHo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+relationship+of+plasma+miR-503+and+coronary+collateral+circulation+in+patients+with+coronary+artery+disease&rft.jtitle=Life+sciences+%281973%29&rft.au=Fei%2C+Yu&rft.au=Hou%2C+Jianhua&rft.au=Xuan%2C+Wei&rft.au=Zhang%2C+Chenghua&rft.date=2018-08-15&rft.issn=0024-3205&rft.volume=207+p.145-151&rft.spage=145&rft.epage=151&rft_id=info:doi/10.1016%2Fj.lfs.2018.06.001&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0024-3205&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0024-3205&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0024-3205&client=summon